Guidance for the design and reporting of studies evaluating the clinical performance of tests for present or past SARS-CoV-2 infection Post date 29 March 2021 ← Anti-amyloid trials raise scientific and ethical questions → Covid vaccine: Prioritise over 16s living with immunosuppressed adults, says JCVI